PPBT
Purple BiotechNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.40M
P/E Ratio
0.00
EPS
$3226.00
Beta
-0.57
52W High
$29.00
52W Low
$2.52
50-Day MA
$4.06
200-Day MA
$7.32
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Purple Biotech
Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United States. The company is headquartered in Rehovot, Israel.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | -59,000 |
| EBITDA | $-7.80M |
| Operating Margin | 0.00% |
| Return on Equity | -123.40% |
| Return on Assets | -19.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.01 |
| Price-to-Book | 0.28 |
| Price-to-Sales (TTM) | 58.08 |
| EV/Revenue | 33.07 |
| EV/EBITDA | -0.15 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 929,460 |
| Float | $1.85B |
| % Insiders | 6.51% |
| % Institutions | 11.44% |
Historical Volatility
HV 10-Day
115.43%
HV 20-Day
91.63%
HV 30-Day
100.13%
HV 60-Day
92.11%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($30.00 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026